PI 3-kinase p110 β Antibodies

Santa Cruz Biotechnology delivers a wide array of PI 3-kinase p110 β monoclonal antibodies for research focused on cellular signaling pathways. PI 3-kinase p110 β monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PI 3-kinase p110 β is a key enzyme involved in the phosphoinositide 3-kinase (PI3K) signaling pathway, which plays a vital role in regulating cell growth, proliferation, and survival. Dysregulation of this pathway is often implicated in various diseases, including cancer and metabolic disorders, making PI 3-kinase p110 β an important target for therapeutic intervention. Understanding the function and regulation of PI 3-kinase p110 β is essential for advancing research in these areas. Researchers can explore PI 3-kinase p110 β activity using specific conjugates, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC). Advanced detection methods enable precise visualization and quantification of PI 3-kinase p110 β in various experimental settings. Multiple formats and conjugates of PI 3-kinase p110 β monoclonal antibodies support diverse research requirements and protocols. Santa Cruz Biotechnology monoclonal antibodies for PI 3-kinase p110 β contribute to advancing scientific understanding of cellular signaling and disease mechanisms.